Billionaire Patrick Soon-Shiong wins wider FDA approval for bladder cancer drug
US regulators expanded approval of ImmunityBio's Anktiva to papillary bladder tumors, months early, lifting the value of Patrick Soon-Shiong's $6.5 billion stake.
Anktiva